Intervention Review

Oxcarbazepine versus phenytoin monotherapy for epilepsy

  1. Martie Muller1,*,
  2. Anthony G Marson2,
  3. Paula R Williamson3

Editorial Group: Cochrane Epilepsy Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 3 APR 2008

DOI: 10.1002/14651858.CD003615.pub2

Database Title

Additional Information

How to Cite

Muller M, Marson AG, Williamson PR. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003615. DOI: 10.1002/14651858.CD003615.pub2.

Author Information

  1. 1

    University of Copenhagen, Department of Life Sciences, Statistics Group, Copenhagen, Denmark

  2. 2

    Clinical Sciences Centre for Research & Education, University Department of Neurological Science, Liverpool, Merseyside, UK

  3. 3

    University of Liverpool, Centre for Medical Statistics and Health Evaluation, Liverpool, Merseyside, UK

*Martie Muller, Department of Life Sciences, Statistics Group, University of Copenhagen, Thorvaldsensvej 40, 1871 Frederiksberg C, Building: Højhus 73, Copenhagen, Denmark. martiemuller@idws.co.za. mmul@life.ku.dk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (60K)Standard (384K)Full (458K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Summary (60K)Standard (384K)Full (458K)